PegIFN Alpha-2a

pegylated interferon alfa-2a · F. Hoffmann-La Roche Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PegIFN Alpha-2a, covering 2015-05-07 to 2015-05-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment [Phase 2]

See pricing